APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bendamustine Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bendamustine Injection Market Analysis and Forecast 2026-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchBendamustine Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Bendamustine Injection Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Bendamustine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bendamustine Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Bendamustine Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Bendamustine Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Bendamustine Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bendamustine Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bendamustine Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bendamustine Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Bendamustine Injection include Eagle Pharmaceuticals, Emcure, Miracalus Pharma, MundiPharma, Natco Pharma, Mylan, Teva and Eisai, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Bendamustine Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bendamustine Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Bendamustine Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bendamustine Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bendamustine Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Bendamustine Injection sales, projected growth trends, production technology, application and end-user industry.

Bendamustine Injection Segment by Company

Eagle Pharmaceuticals

Emcure

Miracalus Pharma

MundiPharma

Natco Pharma

Mylan

Teva

Eisai

Bendamustine Injection Segment by Type

25mg Injection

100mg Injection

Others

Bendamustine Injection Segment by Application

Chronic Lymphocytic Leukemia

Non-Hodgkin's Lymphoma

Multiple Myeloma

Others

Bendamustine Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bendamustine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bendamustine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bendamustine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Bendamustine Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Bendamustine Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bendamustine Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bendamustine Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 25mg Injection Major Manufacturers Table 3. 100mg Injection Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Bendamustine Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Chronic Lymphocytic Leukemia Major Manufacturers Table 7. Non-Hodgkin's Lymphoma Major Manufacturers Table 8. Multiple Myeloma Major Manufacturers Table 9. Others Major Manufacturers Table 10. Bendamustine Injection Industry Trends Table 11. Bendamustine Injection Industry Drivers Table 12. Bendamustine Injection Industry Opportunities and Challenges Table 13. Bendamustine Injection Industry Restraints Table 14. Global Bendamustine Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Bendamustine Injection Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Bendamustine Injection Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Bendamustine Injection Revenue Market Share by Region (2021-2026) Table 18. Global Bendamustine Injection Revenue Market Share by Region (2027-2032) Table 19. Global Bendamustine Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Bendamustine Injection Sales by Region (2021-2026) & (K Units) Table 21. Global Bendamustine Injection Sales by Region (2027-2032) & (K Units) Table 22. Global Bendamustine Injection Sales Market Share by Region (2021-2026) Table 23. Global Bendamustine Injection Sales Market Share by Region (2027-2032) Table 24. Global Bendamustine Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Bendamustine Injection Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Bendamustine Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Bendamustine Injection Sales Market Share by Manufacturers (2021-2026) Table 28. Global Bendamustine Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Bendamustine Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Bendamustine Injection Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Bendamustine Injection Manufacturers, Product Type & Application Table 32. Global Bendamustine Injection Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Bendamustine Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Bendamustine Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Bendamustine Injection Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Bendamustine Injection Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Bendamustine Injection Revenue Market Share by Type (2021-2026) Table 39. Global Bendamustine Injection Revenue Market Share by Type (2027-2032) Table 40. Global Bendamustine Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Bendamustine Injection Sales by Type (2021-2026) & (K Units) Table 42. Global Bendamustine Injection Sales by Type (2027-2032) & (K Units) Table 43. Global Bendamustine Injection Sales Market Share by Type (2021-2026) Table 44. Global Bendamustine Injection Sales Market Share by Type (2027-2032) Table 45. Global Bendamustine Injection Price by Type (2021-2026) & (US$/Unit) Table 46. Global Bendamustine Injection Price by Type (2027-2032) & (US$/Unit) Table 47. Global Bendamustine Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Bendamustine Injection Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Bendamustine Injection Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Bendamustine Injection Revenue Market Share by Application (2021-2026) Table 51. Global Bendamustine Injection Revenue Market Share by Application (2027-2032) Table 52. Global Bendamustine Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Bendamustine Injection Sales by Application (2021-2026) & (K Units) Table 54. Global Bendamustine Injection Sales by Application (2027-2032) & (K Units) Table 55. Global Bendamustine Injection Sales Market Share by Application (2021-2026) Table 56. Global Bendamustine Injection Sales Market Share by Application (2027-2032) Table 57. Global Bendamustine Injection Price by Application (2021-2026) & (US$/Unit) Table 58. Global Bendamustine Injection Price by Application (2027-2032) & (US$/Unit) Table 59. Eagle Pharmaceuticals Company Information Table 60. Eagle Pharmaceuticals Business Overview Table 61. Eagle Pharmaceuticals Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Eagle Pharmaceuticals Bendamustine Injection Product Portfolio Table 63. Eagle Pharmaceuticals Recent Development Table 64. Emcure Company Information Table 65. Emcure Business Overview Table 66. Emcure Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Emcure Bendamustine Injection Product Portfolio Table 68. Emcure Recent Development Table 69. Miracalus Pharma Company Information Table 70. Miracalus Pharma Business Overview Table 71. Miracalus Pharma Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Miracalus Pharma Bendamustine Injection Product Portfolio Table 73. Miracalus Pharma Recent Development Table 74. MundiPharma Company Information Table 75. MundiPharma Business Overview Table 76. MundiPharma Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. MundiPharma Bendamustine Injection Product Portfolio Table 78. MundiPharma Recent Development Table 79. Natco Pharma Company Information Table 80. Natco Pharma Business Overview Table 81. Natco Pharma Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Natco Pharma Bendamustine Injection Product Portfolio Table 83. Natco Pharma Recent Development Table 84. Mylan Company Information Table 85. Mylan Business Overview Table 86. Mylan Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Mylan Bendamustine Injection Product Portfolio Table 88. Mylan Recent Development Table 89. Teva Company Information Table 90. Teva Business Overview Table 91. Teva Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Teva Bendamustine Injection Product Portfolio Table 93. Teva Recent Development Table 94. Eisai Company Information Table 95. Eisai Business Overview Table 96. Eisai Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Eisai Bendamustine Injection Product Portfolio Table 98. Eisai Recent Development Table 99. North America Bendamustine Injection Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Bendamustine Injection Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Bendamustine Injection Sales by Type (2021-2026) & (K Units) Table 102. North America Bendamustine Injection Sales by Type (2027-2032) & (K Units) Table 103. North America Bendamustine Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 104. North America Bendamustine Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 105. North America Bendamustine Injection Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Bendamustine Injection Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Bendamustine Injection Sales by Application (2021-2026) & (K Units) Table 108. North America Bendamustine Injection Sales by Application (2027-2032) & (K Units) Table 109. North America Bendamustine Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 110. North America Bendamustine Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 111. North America Bendamustine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Bendamustine Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. North America Bendamustine Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. North America Bendamustine Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 115. North America Bendamustine Injection Sales by Country (2021-2026) & (K Units) Table 116. North America Bendamustine Injection Sales by Country (2027-2032) & (K Units) Table 117. North America Bendamustine Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 118. North America Bendamustine Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 119. United States Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 120. Canada Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 121. Europe Bendamustine Injection Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Bendamustine Injection Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Bendamustine Injection Sales by Type (2021-2026) & (K Units) Table 124. Europe Bendamustine Injection Sales by Type (2027-2032) & (K Units) Table 125. Europe Bendamustine Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 126. Europe Bendamustine Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 127. Europe Bendamustine Injection Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Bendamustine Injection Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Bendamustine Injection Sales by Application (2021-2026) & (K Units) Table 130. Europe Bendamustine Injection Sales by Application (2027-2032) & (K Units) Table 131. Europe Bendamustine Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 132. Europe Bendamustine Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Europe Bendamustine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Bendamustine Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Bendamustine Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Bendamustine Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 137. Europe Bendamustine Injection Sales by Country (2021-2026) & (K Units) Table 138. Europe Bendamustine Injection Sales by Country (2027-2032) & (K Units) Table 139. Europe Bendamustine Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 140. Europe Bendamustine Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 141. Germany Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 142. France Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 143. U.K. Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 144. Italy Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 145. Netherlands Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 146. China Bendamustine Injection Revenue by Type (2021-2026) & (US$ Million) Table 147. China Bendamustine Injection Revenue by Type (2027-2032) & (US$ Million) Table 148. China Bendamustine Injection Sales by Type (2021-2026) & (K Units) Table 149. China Bendamustine Injection Sales by Type (2027-2032) & (K Units) Table 150. China Bendamustine Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 151. China Bendamustine Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 152. China Bendamustine Injection Revenue by Application (2021-2026) & (US$ Million) Table 153. China Bendamustine Injection Revenue by Application (2027-2032) & (US$ Million) Table 154. China Bendamustine Injection Sales by Application (2021-2026) & (K Units) Table 155. China Bendamustine Injection Sales by Application (2027-2032) & (K Units) Table 156. China Bendamustine Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 157. China Bendamustine Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Bendamustine Injection Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Bendamustine Injection Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Bendamustine Injection Sales by Type (2021-2026) & (K Units) Table 161. Asia Bendamustine Injection Sales by Type (2027-2032) & (K Units) Table 162. Asia Bendamustine Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 163. Asia Bendamustine Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 164. Asia Bendamustine Injection Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Bendamustine Injection Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Bendamustine Injection Sales by Application (2021-2026) & (K Units) Table 167. Asia Bendamustine Injection Sales by Application (2027-2032) & (K Units) Table 168. Asia Bendamustine Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 169. Asia Bendamustine Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Asia Bendamustine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Bendamustine Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Bendamustine Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Bendamustine Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. Asia Bendamustine Injection Sales by Country (2021-2026) & (K Units) Table 175. Asia Bendamustine Injection Sales by Country (2027-2032) & (K Units) Table 176. Asia Bendamustine Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 177. Asia Bendamustine Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Japan Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 179. South Korea Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 180. India Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 181. Australia Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 182. China Taiwan Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Bendamustine Injection Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Bendamustine Injection Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Bendamustine Injection Sales by Type (2021-2026) & (K Units) Table 187. SAMEA Bendamustine Injection Sales by Type (2027-2032) & (K Units) Table 188. SAMEA Bendamustine Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 189. SAMEA Bendamustine Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 190. SAMEA Bendamustine Injection Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Bendamustine Injection Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Bendamustine Injection Sales by Application (2021-2026) & (K Units) Table 193. SAMEA Bendamustine Injection Sales by Application (2027-2032) & (K Units) Table 194. SAMEA Bendamustine Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 195. SAMEA Bendamustine Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 196. SAMEA Bendamustine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Bendamustine Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Bendamustine Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Bendamustine Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 200. SAMEA Bendamustine Injection Sales by Country (2021-2026) & (K Units) Table 201. SAMEA Bendamustine Injection Sales by Country (2027-2032) & (K Units) Table 202. SAMEA Bendamustine Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 203. SAMEA Bendamustine Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 204. Brazil Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 205. Argentina Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 206. Chile Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 207. Colombia Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 208. Peru Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 210. Israel Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 211. UAE Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 212. Turkey Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 213. Iran Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 214. Egypt Bendamustine Injection Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Bendamustine Injection Distributors List Table 218. Bendamustine Injection Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Bendamustine Injection Image Figure 2. Global Bendamustine Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bendamustine Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 25mg Injection Image Figure 5. 100mg Injection Image Figure 6. Others Image Figure 7. Global Bendamustine Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Bendamustine Injection Market Size Share 2021 VS 2025 VS 2032 Figure 9. Chronic Lymphocytic Leukemia Image Figure 10. Non-Hodgkin's Lymphoma Image Figure 11. Multiple Myeloma Image Figure 12. Others Image Figure 13. Global Bendamustine Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Bendamustine Injection Revenue (2021-2032) & (US$ Million) Figure 15. Global Bendamustine Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Bendamustine Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Bendamustine Injection Revenue Market Share by Region (2021-2032) Figure 18. Global Bendamustine Injection Sales (2021-2032) & (K Units) Figure 19. Global Bendamustine Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Bendamustine Injection Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Bendamustine Injection Sales YoY (2021-2032) & (K Units) Figure 22. Europe Bendamustine Injection Sales YoY (2021-2032) & (K Units) Figure 23. China Bendamustine Injection Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Bendamustine Injection Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Bendamustine Injection Sales YoY (2021-2032) & (K Units) Figure 26. Global Bendamustine Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Bendamustine Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Bendamustine Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Bendamustine Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Bendamustine Injection Revenue Market Share by Type (2021-2032) Figure 32. Global Bendamustine Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Bendamustine Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Bendamustine Injection Sales Market Share by Type (2021-2032) Figure 35. Global Bendamustine Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Bendamustine Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Bendamustine Injection Revenue Market Share by Application (2021-2032) Figure 38. Global Bendamustine Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Bendamustine Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Bendamustine Injection Sales Market Share by Application (2021-2032) Figure 41. North America Bendamustine Injection Revenue Share by Type (2021-2032) Figure 42. North America Bendamustine Injection Sales Share by Type (2021-2032) Figure 43. North America Bendamustine Injection Revenue Share by Application (2021-2032) Figure 44. North America Bendamustine Injection Sales Share by Application (2021-2032) Figure 45. North America Bendamustine Injection Revenue Share by Country (2021-2032) Figure 46. North America Bendamustine Injection Sales Share by Country (2021-2032) Figure 47. Europe Bendamustine Injection Revenue Share by Type (2021-2032) Figure 48. Europe Bendamustine Injection Sales Share by Type (2021-2032) Figure 49. Europe Bendamustine Injection Revenue Share by Application (2021-2032) Figure 50. Europe Bendamustine Injection Sales Share by Application (2021-2032) Figure 51. Europe Bendamustine Injection Revenue Share by Country (2021-2032) Figure 52. Europe Bendamustine Injection Sales Share by Country (2021-2032) Figure 53. China Bendamustine Injection Revenue Share by Type (2021-2032) Figure 54. China Bendamustine Injection Sales Share by Type (2021-2032) Figure 55. China Bendamustine Injection Revenue Share by Application (2021-2032) Figure 56. China Bendamustine Injection Sales Share by Application (2021-2032) Figure 57. Asia Bendamustine Injection Revenue Share by Type (2021-2032) Figure 58. Asia Bendamustine Injection Sales Share by Type (2021-2032) Figure 59. Asia Bendamustine Injection Revenue Share by Application (2021-2032) Figure 60. Asia Bendamustine Injection Sales Share by Application (2021-2032) Figure 61. Asia Bendamustine Injection Revenue Share by Country (2021-2032) Figure 62. Asia Bendamustine Injection Sales Share by Country (2021-2032) Figure 63. SAMEA Bendamustine Injection Revenue Share by Type (2021-2032) Figure 64. SAMEA Bendamustine Injection Sales Share by Type (2021-2032) Figure 65. SAMEA Bendamustine Injection Revenue Share by Application (2021-2032) Figure 66. SAMEA Bendamustine Injection Sales Share by Application (2021-2032) Figure 67. SAMEA Bendamustine Injection Revenue Share by Country (2021-2032) Figure 68. SAMEA Bendamustine Injection Sales Share by Country (2021-2032) Figure 69. Bendamustine Injection Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Bendamustine Injection Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 25mg Injection
  • 100mg Injection
  • Others
Applications
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin's Lymphoma
  • Multiple Myeloma
  • Others
Companies covered
  • Eagle Pharmaceuticals
  • Emcure
  • Miracalus Pharma
  • MundiPharma
  • Natco Pharma
  • Mylan
  • Teva
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bendamustine Injection Market by Type
  3. 1.2.1 Global Bendamustine Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 25mg Injection
  5. 1.2.3 100mg Injection
  6. 1.2.4 Others
  7. 1.3 Bendamustine Injection Market by Application
  8. 1.3.1 Global Bendamustine Injection Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Chronic Lymphocytic Leukemia
  10. 1.3.3 Non-Hodgkin's Lymphoma
  11. 1.3.4 Multiple Myeloma
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Bendamustine Injection Market Dynamics
  1. 2.1 Bendamustine Injection Industry Trends
  2. 2.2 Bendamustine Injection Industry Drivers
  3. 2.3 Bendamustine Injection Industry Opportunities and Challenges
  4. 2.4 Bendamustine Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Bendamustine Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Bendamustine Injection Revenue by Region
  3. 3.2.1 Global Bendamustine Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bendamustine Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Bendamustine Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Bendamustine Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Bendamustine Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Bendamustine Injection Sales by Region
  9. 3.4.1 Global Bendamustine Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Bendamustine Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Bendamustine Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Bendamustine Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Bendamustine Injection Revenue by Manufacturers
  2. 4.1.1 Global Bendamustine Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Bendamustine Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Bendamustine Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bendamustine Injection Sales by Manufacturers
  6. 4.2.1 Global Bendamustine Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Bendamustine Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Bendamustine Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Bendamustine Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Bendamustine Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Bendamustine Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Bendamustine Injection Manufacturers, Product Type & Application
  13. 4.7 Global Bendamustine Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Bendamustine Injection Market CR5 and HHI
  16. 4.8.2 2025 Bendamustine Injection Tier 1, Tier 2, and Tier 3
5 Bendamustine Injection Market by Type
  1. 5.1 Global Bendamustine Injection Revenue by Type
  2. 5.1.1 Global Bendamustine Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Bendamustine Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Bendamustine Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Bendamustine Injection Sales by Type
  6. 5.2.1 Global Bendamustine Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bendamustine Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Bendamustine Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Bendamustine Injection Price by Type
6 Bendamustine Injection Market by Application
  1. 6.1 Global Bendamustine Injection Revenue by Application
  2. 6.1.1 Global Bendamustine Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Bendamustine Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Bendamustine Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Bendamustine Injection Sales by Application
  6. 6.2.1 Global Bendamustine Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Bendamustine Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Bendamustine Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Bendamustine Injection Price by Application
7 Company Profiles
  1. 7.1 Eagle Pharmaceuticals
  2. 7.1.1 Eagle Pharmaceuticals Company Information
  3. 7.1.2 Eagle Pharmaceuticals Business Overview
  4. 7.1.3 Eagle Pharmaceuticals Bendamustine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Eagle Pharmaceuticals Bendamustine Injection Product Portfolio
  6. 7.1.5 Eagle Pharmaceuticals Recent Developments
  7. 7.2 Emcure
  8. 7.2.1 Emcure Company Information
  9. 7.2.2 Emcure Business Overview
  10. 7.2.3 Emcure Bendamustine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Emcure Bendamustine Injection Product Portfolio
  12. 7.2.5 Emcure Recent Developments
  13. 7.3 Miracalus Pharma
  14. 7.3.1 Miracalus Pharma Company Information
  15. 7.3.2 Miracalus Pharma Business Overview
  16. 7.3.3 Miracalus Pharma Bendamustine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Miracalus Pharma Bendamustine Injection Product Portfolio
  18. 7.3.5 Miracalus Pharma Recent Developments
  19. 7.4 MundiPharma
  20. 7.4.1 MundiPharma Company Information
  21. 7.4.2 MundiPharma Business Overview
  22. 7.4.3 MundiPharma Bendamustine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 MundiPharma Bendamustine Injection Product Portfolio
  24. 7.4.5 MundiPharma Recent Developments
  25. 7.5 Natco Pharma
  26. 7.5.1 Natco Pharma Company Information
  27. 7.5.2 Natco Pharma Business Overview
  28. 7.5.3 Natco Pharma Bendamustine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Natco Pharma Bendamustine Injection Product Portfolio
  30. 7.5.5 Natco Pharma Recent Developments
  31. 7.6 Mylan
  32. 7.6.1 Mylan Company Information
  33. 7.6.2 Mylan Business Overview
  34. 7.6.3 Mylan Bendamustine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mylan Bendamustine Injection Product Portfolio
  36. 7.6.5 Mylan Recent Developments
  37. 7.7 Teva
  38. 7.7.1 Teva Company Information
  39. 7.7.2 Teva Business Overview
  40. 7.7.3 Teva Bendamustine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Teva Bendamustine Injection Product Portfolio
  42. 7.7.5 Teva Recent Developments
  43. 7.8 Eisai
  44. 7.8.1 Eisai Company Information
  45. 7.8.2 Eisai Business Overview
  46. 7.8.3 Eisai Bendamustine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Eisai Bendamustine Injection Product Portfolio
  48. 7.8.5 Eisai Recent Developments
8 North America
  1. 8.1 North America Bendamustine Injection Market Size by Type
  2. 8.1.1 North America Bendamustine Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Bendamustine Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Bendamustine Injection Price by Type (2021-2032)
  5. 8.2 North America Bendamustine Injection Market Size by Application
  6. 8.2.1 North America Bendamustine Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Bendamustine Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Bendamustine Injection Price by Application (2021-2032)
  9. 8.3 North America Bendamustine Injection Market Size by Country
  10. 8.3.1 North America Bendamustine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Bendamustine Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Bendamustine Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Bendamustine Injection Market Size by Type
  2. 9.1.1 Europe Bendamustine Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Bendamustine Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Bendamustine Injection Price by Type (2021-2032)
  5. 9.2 Europe Bendamustine Injection Market Size by Application
  6. 9.2.1 Europe Bendamustine Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Bendamustine Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Bendamustine Injection Price by Application (2021-2032)
  9. 9.3 Europe Bendamustine Injection Market Size by Country
  10. 9.3.1 Europe Bendamustine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Bendamustine Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Bendamustine Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Bendamustine Injection Market Size by Type
  2. 10.1.1 China Bendamustine Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Bendamustine Injection Sales by Type (2021-2032)
  4. 10.1.3 China Bendamustine Injection Price by Type (2021-2032)
  5. 10.2 China Bendamustine Injection Market Size by Application
  6. 10.2.1 China Bendamustine Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Bendamustine Injection Sales by Application (2021-2032)
  8. 10.2.3 China Bendamustine Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bendamustine Injection Market Size by Type
  2. 11.1.1 Asia Bendamustine Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Bendamustine Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Bendamustine Injection Price by Type (2021-2032)
  5. 11.2 Asia Bendamustine Injection Market Size by Application
  6. 11.2.1 Asia Bendamustine Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Bendamustine Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Bendamustine Injection Price by Application (2021-2032)
  9. 11.3 Asia Bendamustine Injection Market Size by Country
  10. 11.3.1 Asia Bendamustine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Bendamustine Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Bendamustine Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bendamustine Injection Market Size by Type
  2. 12.1.1 SAMEA Bendamustine Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Bendamustine Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Bendamustine Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Bendamustine Injection Market Size by Application
  6. 12.2.1 SAMEA Bendamustine Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Bendamustine Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Bendamustine Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Bendamustine Injection Market Size by Country
  10. 12.3.1 SAMEA Bendamustine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Bendamustine Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Bendamustine Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Bendamustine Injection Value Chain Analysis
  2. 13.1.1 Bendamustine Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Bendamustine Injection Production Mode & Process
  6. 13.2 Bendamustine Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Bendamustine Injection Distributors
  9. 13.2.3 Bendamustine Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst